Global Dry Powder Inhalation Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Dry Powder Inhalation Device market size was valued at US$ 1626 million in 2024 and is forecast to a readjusted size of USD 2587 million by 2031 with a CAGR of 6.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A dry powder inhalation device is a medical device that drives drug powder into the respiratory tract through the patient's active inhalation. Its core design concept is to use the patient's own respiratory airflow to achieve drug delivery without propellant.
Market Concentration and Key Players:
Internationally, the market concentration of dry powder inhalers is relatively high, mainly concentrated on Europe, America and other developed countries. For example, large manufacturers such as GSK, AstraZeneca and Boehringer Ingelheim; from the domestic perspective, dry powder inhalers still have great development space in China.
Manufacturing Process and Market Trends:
The manufacturing process of dry powder inhalers revolves around drug micronization, carrier optimization and device design. The core processes include jet milling, spray drying and supercritical fluid technology, among which the new spray freeze-drying method forms amorphous powder through rapid solidification at low temperature, and combines with reverse gas chromatography to accurately control the surface energy and humidity sensitivity of the powder. The particle size of micronized drug needs to be controlled within 1-5μm to optimize lung deposition. Carriers such as lactose solve the agglomeration problem through electrostatic repulsion and anti-condensation design. The multi-dose reservoir device adopts intelligent filling line to realize efficient production of 100,000 vials per hour. For example, the Ellipta inhaler synchronizes blister foil peeling with dose counting through a precision mechanical structure, ensuring a delivered dose error rate of less than 5%.
At the market level, the global and China share increased. Drivers include a chronic obstructive pulmonary disease patient base of more than 350 million patients, an increased proportion of biologics delivery demand, and intelligent devices integrated with sensors to monitor medication compliance. In terms of technical trend, flexible electronics and 3D printing are integrated to develop curved atomizing nozzle, the detection sensitivity of graphene sensor is improved, and degradable materials reduce environmental burden. At the policy end, China has included 4 types of inhalants into medical insurance through centralized procurement policy to accelerate the process of domestic substitution, such as breaking the import monopoly of healthy budesonide suspension. In the regional market, Southeast Asia shows a super-high growth rate due to the increase of medical investment, becoming a new focus of international pharmaceutical enterprise layout.
This report is a detailed and comprehensive analysis for global Dry Powder Inhalation Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dry Powder Inhalation Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dry Powder Inhalation Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dry Powder Inhalation Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dry Powder Inhalation Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dry Powder Inhalation Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dry Powder Inhalation Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, AptarGroup, H&T Presspart, Vectura Delivery Devices, MannKind Corporation, MicroDose Therapeutx, GSK, Novartis, AstraZeneca, Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dry Powder Inhalation Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Dose
Multiple Doses
Storage Type
Market segment by Application
Asthmatic
COPD
Other
Major players covered
Catalent
AptarGroup
H&T Presspart
Vectura Delivery Devices
MannKind Corporation
MicroDose Therapeutx
GSK
Novartis
AstraZeneca
Boehringer Ingelheim
Orion Pharma
Liquidia Technologies
Teva Pharmaceutical Industries
Chiesi
Hovione
Nemera
Dürr
Shanghai Huarui
Hangzhou Changxi Pharmaceutical
Suzhou Inha Medicine
Shenzhen Resproly Biopharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhalation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dry Powder Inhalation Device, with price, sales quantity, revenue, and global market share of Dry Powder Inhalation Device from 2020 to 2025.
Chapter 3, the Dry Powder Inhalation Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhalation Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dry Powder Inhalation Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dry Powder Inhalation Device.
Chapter 14 and 15, to describe Dry Powder Inhalation Device sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
A dry powder inhalation device is a medical device that drives drug powder into the respiratory tract through the patient's active inhalation. Its core design concept is to use the patient's own respiratory airflow to achieve drug delivery without propellant.
Market Concentration and Key Players:
Internationally, the market concentration of dry powder inhalers is relatively high, mainly concentrated on Europe, America and other developed countries. For example, large manufacturers such as GSK, AstraZeneca and Boehringer Ingelheim; from the domestic perspective, dry powder inhalers still have great development space in China.
Manufacturing Process and Market Trends:
The manufacturing process of dry powder inhalers revolves around drug micronization, carrier optimization and device design. The core processes include jet milling, spray drying and supercritical fluid technology, among which the new spray freeze-drying method forms amorphous powder through rapid solidification at low temperature, and combines with reverse gas chromatography to accurately control the surface energy and humidity sensitivity of the powder. The particle size of micronized drug needs to be controlled within 1-5μm to optimize lung deposition. Carriers such as lactose solve the agglomeration problem through electrostatic repulsion and anti-condensation design. The multi-dose reservoir device adopts intelligent filling line to realize efficient production of 100,000 vials per hour. For example, the Ellipta inhaler synchronizes blister foil peeling with dose counting through a precision mechanical structure, ensuring a delivered dose error rate of less than 5%.
At the market level, the global and China share increased. Drivers include a chronic obstructive pulmonary disease patient base of more than 350 million patients, an increased proportion of biologics delivery demand, and intelligent devices integrated with sensors to monitor medication compliance. In terms of technical trend, flexible electronics and 3D printing are integrated to develop curved atomizing nozzle, the detection sensitivity of graphene sensor is improved, and degradable materials reduce environmental burden. At the policy end, China has included 4 types of inhalants into medical insurance through centralized procurement policy to accelerate the process of domestic substitution, such as breaking the import monopoly of healthy budesonide suspension. In the regional market, Southeast Asia shows a super-high growth rate due to the increase of medical investment, becoming a new focus of international pharmaceutical enterprise layout.
This report is a detailed and comprehensive analysis for global Dry Powder Inhalation Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Dry Powder Inhalation Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dry Powder Inhalation Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dry Powder Inhalation Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Dry Powder Inhalation Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dry Powder Inhalation Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dry Powder Inhalation Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, AptarGroup, H&T Presspart, Vectura Delivery Devices, MannKind Corporation, MicroDose Therapeutx, GSK, Novartis, AstraZeneca, Boehringer Ingelheim, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Dry Powder Inhalation Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Dose
Multiple Doses
Storage Type
Market segment by Application
Asthmatic
COPD
Other
Major players covered
Catalent
AptarGroup
H&T Presspart
Vectura Delivery Devices
MannKind Corporation
MicroDose Therapeutx
GSK
Novartis
AstraZeneca
Boehringer Ingelheim
Orion Pharma
Liquidia Technologies
Teva Pharmaceutical Industries
Chiesi
Hovione
Nemera
Dürr
Shanghai Huarui
Hangzhou Changxi Pharmaceutical
Suzhou Inha Medicine
Shenzhen Resproly Biopharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhalation Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Dry Powder Inhalation Device, with price, sales quantity, revenue, and global market share of Dry Powder Inhalation Device from 2020 to 2025.
Chapter 3, the Dry Powder Inhalation Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhalation Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Dry Powder Inhalation Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Dry Powder Inhalation Device.
Chapter 14 and 15, to describe Dry Powder Inhalation Device sales channel, distributors, customers, research findings and conclusion.
Table of Contents
151 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Dry Powder Inhalation Device by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
